Abstract Views :364 |
PDF Views:1
Authors
Affiliations
1 Jawaharlal Nehru University, New Delhi 110 067, IN
Source
Artha Vijnana: Journal of The Gokhale Institute of Politics and Economics, Vol 44, No 3-4 (2002), Pagination: 317-332
Abstract
The study tests the FDI spillover hypothesis in the Indian Pharmaceutical industry using an unballanced panel data for a sample affirms over the period 1989-90 to 2000-01. The study estimates finn-specific productive efficiency growth for domestic firms from the frontier production function and relates the same to a set of firm-specific attributes along with the variables of foreign presence. The study found that the presence of foreign firms per se may not be important for productivity growth of domestic firms unless it is complemented by the latter's R&D activity or size. Therefore, the study concludes that policy efforts to encourage R&D and some concentration of size of the domestic firms in the industry may be more desirable than passively liberalizing the FDI policy from the point of view of increasing productive efficiency of local enterprises.
